Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 60.50
-4.20 (-6.49%)
At close: Oct 23, 2026
Invicta Diagnostic Revenue
In the fiscal year ending March 31, 2026, Invicta Diagnostic had annual revenue of 330.42M INR with 9.48% growth. Invicta Diagnostic had revenue of 79.81M in the quarter ending March 31, 2026. That makes Invicta Diagnostic the 41,030th largest company in the world by revenue and 4,028th in India.
Revenue
330.42M
Revenue Growth
+9.48%
P/S Ratio
2.46
Revenue / Employee
2.52M
Employees
131
Market Cap
760.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 330.42M | 28.61M | 9.48% |
| Mar 31, 2025 | 301.81M | 142.83M | 89.84% |
| Mar 31, 2024 | 158.98M | 90.55M | 132.33% |
| Mar 31, 2023 | 68.43M | 39.40M | 135.74% |
| Mar 31, 2022 | 29.03M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 839.76M |
| Pramodini Medicare | 622.88M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |